NEW YORK (GenomeWeb) – Hologic reported after the close of the market on Wednesday that revenues for its fiscal fourth quarter grew 6 percent year over year.

For the three months ended Sept. 26, the firm posted total revenues of $702.8 million compared to $660.6 million in Q4 2014, and ahead of the consensus Wall Street estimate of $692.1 million.

On a constant-currency basis and excluding a one-time benefit in the prior year of amending the company's agreement with Roka Bioscience, revenues grew 12 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.

Apr
27
Sponsored by
SeraCare

This webinar is the third in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.